Archive: 20/03/2017
Pembrolizumab shows promise in treatment of mesothelioma
Pembrolizumab, an antibody drug already used to treat other forms of cancer, can be effective in the treatment of the most common form of mesothelioma, according to a new study led by investigators from the Perelman School ...
Mar 20, 2017